HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bone morphogenetic proteins mediate cellular response and, together with Noggin, regulate astrocyte differentiation after spinal cord injury.

Abstract
Bone morphogenetic proteins (BMPs) play a critical role in regulating cell fate determination during central nervous system (CNS) development. In light of recent findings that BMP-2/4/7 expressions are upregulated after spinal cord injury, we hypothesized that the BMP signaling pathway is important in regulating cellular composition in the injured spinal cord. We found that BMP expressions were upregulated in neural stem cells (NSCs), neurons, oligodendrocytes and microglia/macrophages. Increased expression levels of pSmad1/5/8 (downstream molecules of BMP) were detected in neurons, NSCs, astrocytes, oligodendrocytes and oligodendroglial progenitor cells (OPCs). Active astrocytes which form the astroglial scar were probably derived from NSCs, OPCs and resident astrocytes. Since quiescent NSCs in the normal adult spinal cord will proliferate and differentiate actively into neural cells after traumatic injury, we proposed that BMPs can regulate cellular components by controlling NSC differentiation. Neurosphere culture from adult mouse spinal cord showed that BMP-4 promoted astrocyte differentiation from NSCs while suppressing production of neurons and oligodendrocytes. Conversely, inhibition of BMP-4 by Noggin notably decreased the ratio of astrocyte to neuron numbers. However, intrathecal administration of Noggin in the injured spinal cord failed to attenuate glial fibrillar acidic protein (GFAP) expression even though it effectively reduced pSmad expression. Noggin treatment did not block phosphorylation of Stat3 and the induction of GFAP in the injured spinal cord, suggesting that in addition to the BMP/Smad pathway, the JAK/STAT pathway may also be involved in the regulation of GFAP expression after spinal cord injury.
AuthorsQi Xiao, Yang Du, Wutian Wu, Henry K Yip
JournalExperimental neurology (Exp Neurol) Vol. 221 Issue 2 Pg. 353-66 (Feb 2010) ISSN: 1090-2430 [Electronic] United States
PMID20005873 (Publication Type: Journal Article)
CopyrightCopyright 2009 Elsevier Inc. All rights reserved.
Chemical References
  • Bone Morphogenetic Proteins
  • Carrier Proteins
  • Myelin Basic Protein
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • RNA, Messenger
  • noggin protein
  • Bromodeoxyuridine
Topics
  • Animals
  • Astrocytes (drug effects)
  • Bone Morphogenetic Proteins (pharmacology, therapeutic use)
  • Bromodeoxyuridine (metabolism)
  • Carrier Proteins (pharmacology, therapeutic use)
  • Cell Differentiation (drug effects)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Myelin Basic Protein (genetics, metabolism)
  • Nerve Tissue Proteins (genetics, metabolism)
  • Neurons
  • Nuclear Proteins (genetics, metabolism)
  • Oligodendroglia (drug effects)
  • RNA, Messenger (metabolism)
  • Signal Transduction (drug effects, physiology)
  • Spinal Cord Injuries (drug therapy, pathology, physiopathology)
  • Stem Cells (drug effects)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: